Merkies I S J, Schmitz P I M, van der Meché F G A, Samijn J P A, van Doorn P A
Department of Neurology, Daniel den Hoed Cancer Centre, University Hospital Rotterdam/Erasmus University, Rotterdam, Netherlands.
J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):99-104. doi: 10.1136/jnnp.74.1.99.
In the World Health Organisation (WHO) International Classification of Impairments, Disabilities, and Handicaps (ICIDH), it is suggested that various levels of outcome are associated with one another. However, the ICIDH has been criticised on the grounds that it only represents a general, non-specific relation between its entities.
To examine the significance of the ICIDH in immune mediated polyneuropathies.
Four impairment measures (fatigue severity scale, MRC sum score, "INCAT" sensory sum score, grip strength with the Vigorimeter), five disability scales (nine hole peg test, 10 metres walking test, an overall disability sum score (ODSS), Hughes functional grading scale, Rankin scale), and a handicap scale (Rotterdam nine items handicap scale (RIHS9)) were assessed in 113 clinically stable patients (83 with Guillain-Barré syndrome, 22 with chronic inflammatory demyelinating polyneuropathy, eight with a gammopathy related polyneuropathy). Regression analyses with backward and forward stepwise strategies were undertaken to determine the correlation between the various levels of outcome (impairment on disability, impairment on handicap, disability leading to handicap, and impairment plus disability on handicap).
Impairment measures explained a substantial part of disability (R(2) = 0.64) and about half of the variance in handicap (R(2) = 0.52). Disability measures showed a stronger association with handicap (R(2) = 0.76). Combining impairment and disability scales accounted for 77% of the variance in handicap (RIHS9) scores.
In contrast to some suggestions, support for the ICIDH model is found in the current study because significant associations were shown between its various levels in patients with immune mediated polyneuropathies. Further studies are required to examine other possible contributors to deficits in daily life and social functioning in these conditions.
在世界卫生组织(WHO)的《国际功能、残疾和健康分类》(ICIDH)中,表明不同层面的结果相互关联。然而,ICIDH受到批评,理由是它仅代表其各实体之间一般的、非特异性的关系。
研究ICIDH在免疫介导性多发性神经病中的意义。
对113例临床病情稳定的患者(83例吉兰 - 巴雷综合征患者、22例慢性炎性脱髓鞘性多发性神经病患者、8例与丙种球蛋白病相关的多发性神经病患者)评估了四项功能受限指标(疲劳严重程度量表、医学研究委员会(MRC)总分、“INCAT”感觉总分、握力计测量的握力)、五项残疾量表(九孔插板试验、10米步行试验、整体残疾总分(ODSS)、休斯功能分级量表、兰金量表)以及一项残障量表(鹿特丹九项残障量表(RIHS9))。采用向后和向前逐步策略进行回归分析,以确定不同层面结果(功能受限对残疾的影响、功能受限对残障的影响、残疾导致残障、功能受限加残疾对残障的影响)之间的相关性。
功能受限指标解释了残疾的很大一部分(R² = 0.64)以及残障约一半的方差(R² = 0.52)。残疾量表与残障的关联更强(R² = 0.76)。功能受限和残疾量表相结合解释了残障(RIHS9)分数77%的方差。
与一些观点相反,本研究发现支持ICIDH模型,因为在免疫介导性多发性神经病患者中其不同层面之间显示出显著关联。需要进一步研究以考察在这些情况下导致日常生活和社会功能缺陷的其他可能因素。